Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2022

You are here:
  1. Home
  2. 2022

Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Corporate NewsBy adminDecember 20, 2022

Disclosure regarding Rameda acquiring exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Regulatory DisclosuresBy adminDecember 20, 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminDecember 14, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 28, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 20, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 17, 2022

Rameda Reports its 3Q22 Results

Corporate NewsBy adminNovember 15, 2022

Rameda Reports its 3Q22 Results

Corporate NewsBy adminNovember 15, 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminNovember 14, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 6, 2022
→12345…
678
9→

All Rights Reserved © 2024

Go to Top